Asher Alban Chanan-Khan
Independent DirectorDr. Asher Alban Chanan-Khan M.B.B.S., M.D., serves as Independent Director at Cellectar Biosciences, Inc. since June 23, 2021. He serves as Director at Starton Therapeutics, Inc. since September 2020. He serves as Professor of Medicine & Oncology at the Mayo Clinic School of Medicine, a position he has held since 2011. He serves as Member of Scientific Advisory Board at Starton Holdings, Inc. He served as Chair, Department of Hematology & Oncology at the Mayo Clinic, Florida from October 2011 until January 2018. Prior to joining Mayo Clinic, Dr. Chanan-Khan spent over a decade as an attending physician at the Roswell Park Comprehensive Cancer Center. Dr. Chanan-Khan is a Professor of Medicine and Co-Chairman of the Hematologic Malignancies Program at the Mayo Clinic Cancer Center Jacksonville. He is a Board certified hematologist who has been engaged in the development of novel therapeutics and laboratory research in CLL. Dr. Chanan-Khan has actively contributed to bringing various leading therapeutics to patients, including the study of lenalidomide as a treatment option in CLL. He was a tenured member of the Faculty of Medicine at the State University of New York (SUNY) Buffalo. Dr. Chanan-Khan received an M.D. in Hematology/Oncology from New York University and an M.D. in Internal Medicine from Columbia University Vagelos College of Physicians and Surgeons. He received his Bachelor of Medicine and Bachelor of Surgery from the Allama Iqbal Medical College, Punjab University in Lahore Pakistan. In addition, he also completed a fellowship in translational research from Dr. Takeshita’s laboratory at NYU.
公司職務
- 公司名稱Cellectar Biosciences, Inc.股票代碼CLRB職務Independent Director
